Corrigendum: Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition (Front. Oncol., (2021), 11, 709486, 10.3389/fonc.2021.709486)

1Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

An author name was incorrectly spelled as “Bangmang Wang”. The correct spelling is “Bangmao Wang”. In the published article, there was an error in Affiliation 1. Instead of “Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin Institute of Digestive Disease, Tianjin, China”, it should be “Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Disease, Tianjin, China”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. In the published article, there was an error in Affiliation 2. Instead of “Department of Digestive Diseases, General Hospital of Jincheng, Tianjin, China”, it should be “Department of Digestive Diseases, Jincheng General Hospital, Shanxi, China”. The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Cite

CITATION STYLE

APA

Yang, B., Chen, Q., Wan, C., Sun, S., Zhu, L., Zhao, Z., … Wang, B. (2022, March 29). Corrigendum: Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition (Front. Oncol., (2021), 11, 709486, 10.3389/fonc.2021.709486). Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2022.888600

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free